Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 62 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX from Braine-l'Alleud, company number BE0550716015, closed financial year 2025 with a result of € 132,173 after tax. For that financial year DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX recorded a gross margin of € 274,131 and equity of € 1 million. Compared with financial year 2024, the result moved from € 98,805 to € 132,173. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 4, 2025.
€ 1 million
▲ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 132,173
▲ 34% vs 2024
Profit after tax over the fiscal year.
€ 250,346
▲ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1 million.
People and assets in 2025
€ 38,393
▲ 18% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 560
▼ 35% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,984
▲ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 19,209
▲ 37% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 333,123 | € 342,059 | € 223,764 | € 274,131 | ▲ 23% |
| Profit after taxes | € 168,901 | € 184,305 | € 98,805 | € 132,173 | ▲ 34% |
| Equity | € 625,867 | € 810,171 | € 908,976 | € 1,041,149 | ▲ 15% |
| Total debts | € 655,664 | € 625,414 | € 656,493 | € 448,174 | ▼ 32% |
| Cash | € 875,647 | € 674,921 | € 241,698 | € 250,346 | ▲ 4% |
| Retained profit | € 607,267 | € 791,571 | € 890,376 | € 1,022,549 | ▲ 15% |
| Dividend | € 100,951 | € 0 | € 0 | € 0 | |
| Bank debt | € 13,333 | € 0 | € 8,493 | € 0 | ▼ 100% |
| Balance sheet total | € 1,281,531 | € 1,435,586 | € 1,565,470 | € 1,489,323 | ▼ 5% |
Key figures of DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX?
What happened at DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 132,173 (▲ 34% vs 2024). Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 168,901 profit in 2022 to € 132,173 profit in 2025.
Paid € 250,705 in corporate taxes since 2022.
Best year ever: 2023, with € 184,305 profit.
Paid out € 100,951 in dividends to the owners in total.
A new publication or filing at DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX? We notify you, reason included.
Follow DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUXDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX is IMMO LEBLANC SRL. It owns 1% of IMMO LEBLANC itself.
Directors
According to the 2025 annual accounts
Director · represented by MARC LEBLANC
Establishments
Establishment units
Physical locations of this company
Clos Béliau 16
1421 Braine-l'Alleud
Rue du Parc 19
6000 Charleroi
Active since 24 April 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0550.716.015
- VAT number
- BE 0550.716.015
- Registered office
- Clos Béliau 16, 1421 Braine-l'Alleud
- Names & denominations
- DR MARC LEBLANC-MALADIE ET CHIRURGIE DES YEUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 April 2014
- Peppol
- Active · Active since 2 Apr 2026
- Activities · NACE
Activiteiten van medisch specialisten